KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Short-term Investments (2017 - 2024)

Historic Short-term Investments for Guardant Health (GH) over the last 8 years, with Q4 2024 value amounting to $314.4 million.

  • Guardant Health's Short-term Investments rose 79591.13% to $314.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $314.4 million, marking a year-over-year increase of 79591.13%. This contributed to the annual value of $314.4 million for FY2024, which is 79591.13% up from last year.
  • Latest data reveals that Guardant Health reported Short-term Investments of $314.4 million as of Q4 2024, which was up 79591.13% from $310.7 million recorded in Q3 2024.
  • Guardant Health's 5-year Short-term Investments high stood at $1.1 billion for Q1 2021, and its period low was $35.1 million during Q4 2023.
  • Over the past 5 years, Guardant Health's median Short-term Investments value was $705.4 million (recorded in 2023), while the average stood at $650.7 million.
  • As far as peak fluctuations go, Guardant Health's Short-term Investments crashed by 9596.39% in 2023, and later soared by 79591.13% in 2024.
  • Quarter analysis of 5 years shows Guardant Health's Short-term Investments stood at $961.9 million in 2020, then crashed by 54.2% to $440.5 million in 2021, then soared by 97.39% to $869.6 million in 2022, then tumbled by 95.96% to $35.1 million in 2023, then surged by 795.91% to $314.4 million in 2024.
  • Its last three reported values are $314.4 million in Q4 2024, $310.7 million for Q3 2024, and $35.1 million during Q4 2023.